跳至主要内容
临床试验/NCT01873690
NCT01873690终止3 期

A Randomized Controlled Trial Assessing the Efficacy of Antimicrobial Prophylaxis for Extracorporeal Shock Wave Lithotripsy on Reducing Urinary Tract Infection

Lawson Health Research Institute1 个研究点 分布在 1 个国家目标入组 360 人开始时间: 2013年11月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
终止
入组人数
360
试验地点
1
主要终点
Impact of antibiotic prophylaxis on the rate of urinary tract infection

研究概览

简要总结

The purpose of this research study is to test whether administering one dose of an antibiotic before a routine shock wave lithotripsy procedure is more effective at avoiding any urinary infections compared to not taking an antibiotic. This is an important topic to study because urinary tract infections are one of the most common complications after this procedure and there is no clear standard of care regarding the use of pre-procedure antibiotics. Our study results will benefit future patients either by decreasing the rate of infections or decreasing the use of unnecessary antibiotics.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Scheduled for SWL at St. Joseph's Hospital;
  • 18 years of age or older;
  • Willing and able to complete Questionnaires;
  • Willing to submit urine sample for analysis at Day 7;
  • Able to read and speak English.

排除标准

  • Pre-SWL urine analysis positive for nitrites or urine culture reveals >105 CFU/ml of bacteria (positive urine culture);
  • Taking antibiotics for UTI or other cause;
  • Requires an antibiotic post SWL;
  • Suspected struvite stone (based on previous stone analysis, or partial staghorn);
  • Presence of nephrostomy tube;
  • Requiring cystoscopy on the day of SWL;
  • Requiring ureteral stent on the day of SWL;
  • Presence of indwelling urinary catheter or on regular clean intermittent catheterization (CIC);
  • Presence of urinary diversion (ie: ileal conduit);
  • Any history of urosepsis;
  • Known allergic reaction to ciprofloxacin/quinolones;
  • Patient known to be pregnant;
  • Previous randomization in this trial;
  • In the opinion of the urologist, it is not in the patient's best interest to participate.

研究组 & 干预措施

Placebo

Placebo Comparator

Placebo

干预措施: Placebo (Drug)

Ciprofloxacin

Active Comparator

Ciprofloxacin

干预措施: Ciprofloxacin (Drug)

结局指标

主要结局

Impact of antibiotic prophylaxis on the rate of urinary tract infection

时间窗: Post SWL Day 7

Our primary outcome will be a composite endpoint comprised of: Positive post-SWL urine culture (≥ 105 colony forming units / millilitre (CFU/ml), symptoms of cystitis (defined as new onset burning sensation or pain with voiding, frequency, urgency), or pyelonephritis or urosepsis (hospital admission with fever ≥38.5 C).

次要结局

  • Bacteriuria post-SWL (≥105 cfu/ml)(7-14 days)
  • Symptoms of cystitis (new onset burning sensation or pain with voiding, frequency, urgency)(7-14 days)
  • Pyelonephritis or urosepsis (hospital admission with fever ≥38.5C)(7-14 days)
  • Change in Urinary Symptom Score(reported as positive or negative integer)(7 - 14 days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Hassan Razvi

Principle Investigator

Lawson Health Research Institute

研究点 (1)

Loading locations...

相似试验